Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B – Endpoints News
It’s becoming Hengrui Pharma’s world, and some Western drugmakers are just living in it.
China’s largest pharma company, which boasts one of the biggest pipelines …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
